Stocks
Journey Medical CorporationDERM
NASDAQHealthcareBiotechnology$5.41
Price as of · delayed, not real-time
A commercial-stage biopharmaceutical company focused on developing and commercializing dermatological products, with a lead asset for the treatment of rosacea. Its portfolio includes branded and generic prescription drugs targeting conditions such as acne, fungal infections, and actinic keratosis. Investors track the company for its revenue growth from recently launched products and its path to profitability.
52W Range: $4.31-$9.55
Congressional Interest in Journey Medical Corporation (DERM)
1 member of Congress has disclosed 1 trade in Journey Medical Corporation (DERM), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading DERM?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-11-28 | CHARLES J. "CHUCK" FLEISCHMANN | buy | $1K-$15K |